Published in Acta Biochim Biophys Sin (Shanghai) on November 29, 2011
Inflammatory pathways of importance for management of inflammatory bowel disease. World J Gastroenterol (2014) 1.09
WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells. Cancer Sci (2014) 0.85
Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Biomed Res Int (2015) 0.79
Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor. Mol Cell Biol (2015) 0.78
The brain parenchyma has a type I interferon response that can limit virus spread. Proc Natl Acad Sci U S A (2016) 0.75
A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med (2005) 21.48
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet (2005) 18.59
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature (2005) 18.43
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell (2005) 17.41
A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol (2008) 14.74
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol (2002) 9.30
Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity (1999) 8.33
SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol (2007) 6.89
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell (1993) 6.83
A new protein containing an SH2 domain that inhibits JAK kinases. Nature (1997) 6.28
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature (2011) 5.78
Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity (1999) 5.34
Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science (1993) 5.22
The JAK-STAT signaling pathway: input and output integration. J Immunol (2007) 4.92
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 4.39
The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol (2004) 3.76
Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci U S A (2006) 3.66
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science (2003) 3.19
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (1995) 2.93
Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science (1994) 2.78
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 2.70
Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell (2006) 2.69
Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol Cell Biol (1997) 2.51
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem (2001) 2.29
Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs. Arthritis Rheum (2012) 2.23
The Janus kinases (Jaks). Genome Biol (2004) 2.18
Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity (2000) 2.17
Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med (2005) 2.15
The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. J Biol Chem (2002) 2.14
Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate. Arthritis Care Res (Hoboken) (2011) 2.06
Therapeutic targeting of Janus kinases. Immunol Rev (2008) 2.03
Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med (2001) 2.02
tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene (1990) 1.95
Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol (2002) 1.92
FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma. Blood (2011) 1.86
The SCF ubiquitin ligase: an extended look. Mol Cell (2002) 1.84
Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J (2003) 1.73
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity (2000) 1.69
Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation. Immunity (2008) 1.62
Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol Cell (2001) 1.61
The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc Natl Acad Sci U S A (1997) 1.53
Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol (1997) 1.52
An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int Immunol (2011) 1.48
Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity. Proc Natl Acad Sci U S A (1997) 1.47
Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. Mol Cell Biol (2004) 1.46
Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol (2001) 1.44
SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei. J Biol Chem (2002) 1.44
Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc Natl Acad Sci U S A (2002) 1.42
Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J Biol Chem (1995) 1.41
The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase. J Mol Biol (2008) 1.39
Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol Cell Biol (2000) 1.38
Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther (2011) 1.35
The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression. J Mol Biol (2009) 1.35
Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood (1997) 1.34
Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity. Mol Cell Biol (2007) 1.34
Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res (1999) 1.32
Protein destruction: adapting roles for Cks proteins. Curr Biol (2001) 1.31
The specificity of JAK3 kinase inhibitors. Blood (2007) 1.28
A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling. Proc Natl Acad Sci U S A (2000) 1.27
Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist. J Immunol (2007) 1.27
Phosphorylation of Jak2 on Ser(523) inhibits Jak2-dependent leptin receptor signaling. Mol Cell Biol (2006) 1.23
A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci U S A (2003) 1.19
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood (2009) 1.16
JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene (1994) 1.16
The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing. J Leukoc Biol (2004) 1.16
Targeting the Jak/STAT pathway for immunosuppression. Ann Rheum Dis (2004) 1.16
The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models. Am J Transplant (2004) 1.14
SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor. J Biol Chem (2003) 1.12
Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice. Int Immunol (2000) 1.12
Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor. Mol Cell Biol (2006) 1.12
Peripheral expression of Jak3 is required to maintain T lymphocyte function. J Exp Med (1997) 1.11
Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. EMBO J (2006) 1.11
Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis. Arthritis Res Ther (2008) 1.10
The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression. J Biol Chem (2005) 1.10
JAK3: a two-faced player in hematological disorders. Int J Biochem Cell Biol (2009) 1.10
Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts. Transplantation (2005) 1.09
Cutting edge: an alternative pathway of CD4+ T cell differentiation is induced following activation in the absence of gamma-chain-dependent cytokine signals. J Immunol (2006) 1.06
Matching SOCS with function. Nat Immunol (2003) 1.05
Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates. Transplantation (2005) 1.04
Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells. Blood (1996) 1.00
A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1). Protein Eng (2003) 0.98
Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3. Structure (2006) 0.97
Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes. Cell Res (2010) 0.96
Dual role of the Jak1 FERM and kinase domains in cytokine receptor binding and in stimulation-dependent Jak activation. J Immunol (2008) 0.95
Regulation of lymphocyte development by cell-type-specific interpretation of Notch signals. Mol Cell Biol (2008) 0.94
T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis. J Immunol (1997) 0.94
Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity. Mol Cell Biol (2008) 0.94
A profound deficiency in thymic progenitor cells in mice lacking Jak3. J Immunol (2000) 0.91
Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway. Cell Signal (2008) 0.89
Targeting JAK3 in kidney transplantation: current status and future options. Curr Opin Organ Transplant (2011) 0.88
Crucial role of Jak3 in negative selection of self-reactive T cells. J Exp Med (1997) 0.87
A mechanism underlying NOTCH-induced and ubiquitin-mediated JAK3 degradation. J Biol Chem (2011) 0.87
4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells. Clin Cancer Res (1998) 0.85
Janus kinase 3: a novel target for selective transplant immunosupression. Expert Opin Ther Targets (2004) 0.85
Genomic sequence, organization, and chromosomal localization of human JAK3. Genomics (1996) 0.80
Two members of the JAK family of protein tyrosine kinases map to chromosomes 1p31.3 and 9p24. Mamm Genome (1992) 0.77
The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development. Blood (2009) 1.97
Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J (2003) 1.73
Japanese encephalitis outbreak, Yuncheng, China, 2006. Emerg Infect Dis (2007) 1.56
STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta. EMBO J (2003) 1.53
Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol (2011) 1.46
Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance. Blood (2007) 1.39
Temperature can influence gastric accommodation and sensitivity in functional dyspepsia with epigastric pain syndrome. Dig Dis Sci (2012) 1.38
Primitive lymphoid progenitors in bone marrow with T lineage reconstituting potential. J Immunol (2006) 1.33
Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. Blood (2007) 1.32
Isolation and characterization of the full coding sequence of a novel densovirus from the mosquito Culex pipiens pallens. J Gen Virol (2008) 1.20
Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood (2009) 1.17
Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions. Blood (2008) 1.16
Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination. Mol Cell Biol (2004) 1.10
Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities. Immunity (2002) 1.10
Banna virus, China, 1987-2007. Emerg Infect Dis (2010) 0.99
Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes. Cell Res (2010) 0.96
Regulation of lymphocyte development by cell-type-specific interpretation of Notch signals. Mol Cell Biol (2008) 0.94
Id1 attenuates Notch signaling and impairs T-cell commitment by elevating Deltex1 expression. Mol Cell Biol (2009) 0.92
Genetic diversity analyses of antimicrobial resistance genes in clinical Chryseobacterium meningosepticum isolated from Hefei, China. Int J Antimicrob Agents (2012) 0.92
Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes. Mol Cell Biol (2004) 0.92
Id1 potentiates NF-kappaB activation upon T cell receptor signaling. J Biol Chem (2006) 0.92
Hes1 potentiates T cell lymphomagenesis by up-regulating a subset of notch target genes. PLoS One (2009) 0.92
Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP. J Biol Chem (2007) 0.92
[0507JS60 virus isolated in Xinjiang was identified as Liaoning virus]. Bing Du Xue Bao (2008) 0.91
Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. Neurobiol Aging (2010) 0.90
Sciatic nerve repair by acellular nerve xenografts implanted with BMSCs in rats xenograft combined with BMSCs. Synapse (2011) 0.87
Chronic TLR signaling impairs the long-term repopulating potential of hematopoietic stem cells of wild type but not Id1 deficient mice. PLoS One (2013) 0.87
A mechanism underlying NOTCH-induced and ubiquitin-mediated JAK3 degradation. J Biol Chem (2011) 0.87
Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets. J Immunol (2013) 0.85
Lymphoid lineage cells in adult murine bone marrow diverge from those of other blood cells at an early, hormone-sensitive stage. Semin Immunol (2002) 0.84
[Isolation and identification of arboviruses from mosquito pools in some regions of Liaoning province, China]. Zhonghua Liu Xing Bing Xue Za Zhi (2009) 0.83
Monocytes and Alzheimer's disease. Neurosci Bull (2011) 0.81
Investigation on the chemical constituents and variation of the flower buds of Lonicera species by UPLC-ESI-MS/MS and principle component analysis. Yao Xue Xue Bao (2009) 0.80
Experimental study of low dose ultrashortwave promoting nerve regeneration after acellular nerve allografts repairing the sciatic nerve gap of rats. Cell Mol Neurobiol (2007) 0.80
Determination of atractylenolide II in rat plasma by reversed-phase high-performance liquid chromatography. Biomed Chromatogr (2007) 0.79
Id1 induces apoptosis through inhibition of RORgammat expression. BMC Immunol (2008) 0.78
Enhanced Notch activation is advantageous but not essential for T cell lymphomagenesis in Id1 transgenic mice. PLoS One (2012) 0.77
Gatekeeper mechanisms for immature B cells. Nat Immunol (2002) 0.77
Effects of 660-nm gallium-aluminum-arsenide low-energy laser on nerve regeneration after acellular nerve allograft in rats. Synapse (2010) 0.76
[Discussion of time and space differentiation of three-yin and three-yang in Shanghan Lun]. Zhong Xi Yi Jie He Xue Bao (2005) 0.76
Id1 expression promotes peripheral CD4+ T cell proliferation and survival upon TCR activation without co-stimulation. Biochem Biophys Res Commun (2013) 0.76
Id1 has a physiological role in regulating early B lymphopoiesis. Cell Mol Immunol (2010) 0.76
Notch-regulated periphery B cell differentiation involves suppression of E protein function. J Immunol (2013) 0.76
E proteins regulate osteoclast maturation and survival. J Bone Miner Res (2012) 0.75
[New type of cytoplasmic polyhedrosis virus isolated from mosquitoes in China]. Bing Du Xue Bao (2008) 0.75
Spectroscopic and molecular modeling studies on the interaction between a fluorine-containing triazole derivative and human serum albumin. Biol Trace Elem Res (2010) 0.75
Spectroscopic studies on the interaction of fluorine containing triazole with bovine serum albumin. Biol Trace Elem Res (2010) 0.75
[Analysis of microbial community structure in lactic acid fermentation from kitchen waste]. Huan Jing Ke Xue (2012) 0.75
Effects of glutamate and MK-801 on the metabolism of dopamine in the striatum of normal and parkinsonian rats. Sheng Li Xue Bao (2005) 0.75
[Effect of combined drug treatment on megacolon with severe constipation]. Zhonghua Yi Xue Za Zhi (2007) 0.75
Biocompatibility of acellular nerves of different mammalian species for nerve tissue engineering. Artif Cells Blood Substit Immobil Biotechnol (2011) 0.75
[Value of CODEHOP RT-pCR in detection of Flavivirus]. Bing Du Xue Bao (2014) 0.75